1. Background
2. Objectives
3. Methods
3.1. Experimental Design
3.2. Induction of Diabetes in Rats
3.3. Detection and Maintenance of Leeches
3.4. Method of Leech Therapy
3.5. Animal Treatments
3.6. Histopathological Examination
3.7. Blood Drawing for Enzymatic Assays
3.8. Statistical Analysis
4. Results
4.1. Effect of Diabetes and Leech Therapy on Glucose Serum
| Groups | CG | DG | CHTG | DHTG | P-Value |
|---|---|---|---|---|---|
| Glucose, mg/dL | 121.83 ± 7.13 A | 290.60 ± 50.52 B | 114.5 ± 10.87 A | 319.50 ± 60.37 C | 0.001 |
| TG, mg/dL | 72.83 ± 22.30 C | 75.00 ± 8.86 C | 69.25 ± 28.92 C | 70.66 ± 15.98 C | 0.97 |
| Cholesterol, mg/dL | 60.33 ± 6.56 C | 58.00 ± 8.15 C | 62.25 ± 8.61 C | 62.83 ± 12.81 C | 0.84 |
| HDL, mg/dL | 25.63 ± 1.81 C | 19.19 ± 2.89 B | 28.57 ± 1.32 C | 19.46 ± 1.55 B | 0.001 |
| LDL, mg/dL | 20.58 ± 2.10 B | 33.88 ± 4.57 C | 21.00 ± 2.04 B | 24.68 ± 2.05 B | 0.001 |
Abbreviations: CG, control group, CHTG, control hirudotherapy group, DG, diabetic group; DHTG, diabetic hirudotherapy group.
a Data presented as mean ± SEM. The number of samples in each group is n= 6. Non-similar letters in each row indicate statistically significant differences (P ≤ 0.05). Dissimilar letters in each row indicate a significant difference.
4.2. Effect of Diabetes and Leech Therapy on Lipid Profile Serum
4.3. Effect of Diabetes and Leech Therapy on AST, ALT, ALT, and LDH Activities
| Group | CG | DG | CHTG | DHTG | P-Value |
|---|---|---|---|---|---|
| AST, IU/L | 83.33 ± 12.69 A | 92.40 ± 19.56 A | 104.50 ± 17.54 A,B | 136.83 ± 33.40 B | 0.005 |
| ALT, IU/L | 44.50 ± 3.20 A | 74.20 ± 26.17 A,B | 50.75 ± 10.90 A | 96.00 ± 62.09 B | 0.046 |
| ALP, IU/L | 426.00 ± 62.29 A | 955.40 ± 516.59 A,B | 701.50 ± 72.49 A,B | 1075.00 ± 429.81 B | 0.024 |
| LDH, IU/L | 732.16 ± 248.27 A | 559.20 ± 168.71 A | 619.50 ± 229.14 A | 1421.00 ± 262.3 B | 0.001 |
| Cr, mg/dL | 0.76 ± 0.05 A | 1.04 ± 0.11 A,B | 0.95 ± 0.36 A,B | 1.08 ± 0.26 B | 0.049 |
| Urea, mg/dL | 40.33 ± 4.76 C | 72.00 ± 5.61 A | 44.75 ± 8.61 C | 89.16 ± 12.43 B | 0.001 |
| Ca, mg/dL | 10.46 ± 0.23 B | 10.18 ± 0.73 B | 10.72 ± 0.82 B | 10.58 ± 0.6 B | 0.57 |
| P, mg/dL | 5.58 ± 0.27 A | 7.14 ± 1.89 A,B | 7.90 ± 1.19 A,B | 8.66 ± 1.04 B | 0.003 |
Abbreviations: CG, control group, CHTG, control hirudotherapy group, DG, diabetic group. DHTG, diabetic hirudotherapy group.
a Data presented as mean ± SEM. The number of samples in each group is n = 6. Non-similar letters in each row indicate statistically significant differences (P ≤ 0.05). Dissimilar letters in each row indicate a significant difference.
4.4. Effect of Diabetic and Leech Therapy on Creatinine and Urea Activities
4.5. Effect of Diabetic and Leech Therapy on Calcium and Phosphorus Serum
4.6. Histopathological Findings
(A) The liver of healthy male rats treated with leeches, mononuclear inflammatory cells in the portal area (red arrow), and scattered necrosis foci (red arrowhead) (H&E × 100). (B) Liver of diabetic male rats treated with leeches. Focal exudation of inflammatory cells (red arrowhead) and increase of mononuclear inflammatory cells (red arrow) and bile duct hyperplasia (black arrow) in the portal tract (H&E × 100). (C) The tissue kidney of healthy rats (H & E × 100). (D) The tissue kidney of diabetics treated with leeches, squamous metaplasia of the renal tubular cells due to tubular dilation (red arrow), and necrosis of renal tubules (red arrowhead) (H & E × 100). (E) Pancreatic tissue of control group rats. The structure of the natural Langerhans Islands (red arrow) (H&E × 400). (F) Pancreatic tissue of leech-treated diabetic rats, Langerhans Islands necrosis (red arrow). (H&E × 400). (G) Pancreatic tissue of healthy male rats treated with leeches (H&E × 100).

